Gossamer Bio Inc logo

GOSS

Gossamer Bio Inc

$13.62

Earnings Summary

Revenue
$0Mn
Net Profits
$-57.79Mn
Net Profit Margins
-Inf%

Highlights

Revenue:

Gossamer Bio Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q1 2022. On a quarterly growth basis, Gossamer Bio Inc has generated NaN% jump in its revenue since last 3-months.

Net Profits:

Gossamer Bio Inc’s net profit fell -0.25% since last year same period to $-57.79Mn in the Q1 2022. On a quarterly growth basis, Gossamer Bio Inc has generated 75.31% jump in its net profits since last 3-months.

Net Profit Margins:

Gossamer Bio Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q1 2022. On a quarterly growth basis, Gossamer Bio Inc has generated NaN% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Gossamer Bio Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.7
EPS Estimate Current Year
-0.7

Highlights

EPS Estimate Current Quarter:

Gossamer Bio Inc’s earning per share (EPS) estimates for the current quarter stand at -0.7 - a 9.09% jump from last quarter’s estimates.

EPS Estimate Current Year:

Gossamer Bio Inc’s earning per share (EPS) estimates for the current year stand at -0.7.

Key Ratios

Key ratios of the Gossamer Bio Inc post its Q1 2022 earnings

Earning Per Share (EPS)
-0.76
Return on Assets (ROA)
-0.39
Return on Equity (ROE)
-2.26
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Gossamer Bio Inc’s earning per share (EPS) jumped 2.56% since last year same period to -0.76 in the Q1 2022. This indicates that the Gossamer Bio Inc has generated 2.56% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Gossamer Bio Inc’s return on assets (ROA) stands at -0.39.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Gossamer Bio Inc’s return on equity (ROE) stands at -2.26.

Dividend Per Share (DPS):

Gossamer Bio Inc declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-10
-0.77
-0.76
1.3%

Company Information

Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.

Organisation
Gossamer Bio Inc
Headquarters
San Diego, California, US
Employees
196
Industry
Pharmaceuticals: Major
CEO
Sheila Gujrathi